circAMOTL1 was shown to suppress cell apoptosis through anti- and pro-apoptotic protein expressions by regulating the AKT pathway, suggesting that circAMOTL1 may be a new potential target of breast cancer treatment to reduce the resistance to PAX [37]. Here, AKT1 is linked to breast cancer.